Company page

Xeris Biopharma Holdings, Inc.

Xeris Biopharma Holdings, Inc. is a public company traded under the ticker XERS in the American market. The company has a market capitalization of approximately $1.2 billion. Xeris focuses on developing and commercializing innovative therapeutics using its proprietary formulation technologies.

profileXERS:NASDAQAI content: aiUpdated June 24, 2026/company/xeris-pharmaceuticals-inc/c-ndxuzsxw
Xeris Biopharma Holdings, Inc. logo
Ticker
XERS:NASDAQ
Asset type
Stock
Market cap
$1.20B
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD